Treating Nonalcoholic Fatty Liver and Steatohepatitis Diseases: Real lasting Solutions with the Experts

Treating Nonalcoholic Fatty Liver and Steatohepatitis Diseases

Treating Nonalcoholic Fatty Liver and Steatohepatitis Diseases

In our previous article we looked at the causes and consequences of nonalcoholic fatty liver and steatohepatitis disease broadly. Guided by that we want to find treatment solutions of this uncalled for health condition. Whereas prevention is the best approach of all possible health conditions, we often find ourselves suffering from certain health conditions which could have otherwise been prevented. Therefore if you are in anyway suffering from any weight related condition, help is on the way at AWAREmed Health and Wellness Resource Center under Doctor Akoury’s care. Doctor Akoury is an expert of several decades of experience in matters relating to being overweight, obesity addiction and beauty among many other disciplines. She has been of great help to many people across the globe and your situation will be very safe in her care. You can schedule for an appointment with her even as we get into the discussion about treating nonalcoholic fatty liver and steatohepatitis diseases in this article.

Treating Nonalcoholic Fatty Liver and Steatohepatitis Diseases: Treatment Solutions

Losing excess weight is the best for treatment of nonalcoholic fatty liver and steatohepatitis diseases. In one of the studies it was established that among obese individuals with elevated transaminases, weight gain led to an increase in the level of the liver enzymes. The good news is that even with a minimal weight loss of 10% can impact significantly to the decrease in the levels of the enzymes even to the point of being normal. The decrease in enzymes happened at the rate of 8% for every 1% loss of body weight. In another study where patients undergoing stomach (gastric) reduction operations for morbid obesity were involved, substantial weight loss is accompanied by a marked reduction in transaminases and a regression (improvement) of nonalcoholic fatty liver disease.

Nevertheless medical professionals are using certain medications to treat nonalcoholic fatty liver disease. Like for instance, insulin-sensitizing agents, like:

  • The thiazolidinedione’s
  • Pioglitazone (Actos)
  • Rosiglitazone (Avandia)
  • Metformin (Glucophage)

These medications do not only help to control blood glucose in patients with diabetes, but they also improve enzyme levels in patients with Nonalcoholic fatty liver disease. Remember that medications in the statin class of drugs like atorvastatin/Lipitor decrease the bad LDL cholesterol and, improve enzyme levels among patients with atorvastatin. However a lot more needs to be done to establish the accuracy of these medications if they can also reduce the amount of fat and inflammation in the liver.

Even though a lot more is being done towards treating nonalcoholic fatty liver and steatohepatitis diseases, the most appropriate, effective and accurate treatment for obese people with Nonalcoholic steatohepatitis is to simply losing weight through good nutrition diet and meaningful engagement in physical activities. Much as one may be willing to effectively lose weight, committing to the weight loss assignment may not be as easy as people may want to believe. More so in a society dominated by inactive lifestyle and consumption of wrong food stuff rich in high-calorie, high-carbohydrate and high-fat diets. Doctor Akoury being an expert in this discipline brings forth this advice. Losing weight is very possible, but there must be the self-conviction to take the challenge. Up on consenting then you can begin the weight loss recovery journey by scheduling for an appointment with the experts at AWAREmed Health and Wellness Resource Center under the able leadership of Doctor Akoury’s care. Losing weight is possible and achievable with the expertise you will receive from these experts. Moreover in view of the possible harmful effects of fat in other liver diseases, losing weight forms part of the treatment of other liver diseases which are not necessarily as a result of fat such as hepatitis C. Eventually nonalcoholic steatohepatitis possibly can be prevented and eliminated all together by promoting healthy feeding habits and active lifestyles in children at a tender age.

Treating Nonalcoholic Fatty Liver and Steatohepatitis Diseases: Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)

  • Accumulation of fat in the liver (fatty liver) is common in all stages of nonalcoholic fatty liver disease (NAFLD). The initial stage in the spectrum of nonalcoholic fatty liver disease is fatty liver (steatosis).
  • The basic cause of nonalcoholic fatty liver disease is insulin resistance, a condition in which the effects of insulin on cells within the body are reduced. The most frequent risk factor for insulin resistance is obesity, especially abdominal obesity.
  • Fatty liver is itself quite harmless, disappears rapidly with loss of weight, and infrequently progresses to Nonalcoholic steatohepatitis, which is the next stage of nonalcoholic fatty liver disease.
  • In Nonalcoholic steatohepatitis there is accumulation of fat in the liver, but there also is inflammation (hepatitis), destruction (necrosis) of liver cells, and scarring (fibrosis) of the liver. The scarring can progress to cirrhosis, which is the last stage of nonalcoholic fatty liver disease.
  • The risk factors, the time-line, and the processes (mechanisms) responsible for progression through the stages of Nonalcoholic fatty liver disease are still unclear.
  • The presumptive diagnosis of Nonalcoholic fatty liver disease or Nonalcoholic steatohepatitis is made in individuals who are insulin resistant, have mildly elevated liver enzymes in the blood, and have signs of fatty liver on an ultrasound. These patients must have no other cause for the abnormal enzymes or for the fatty liver, particularly no excessive use of alcohol.
  • If weight loss results in a decrease or normalization of the liver enzymes, the diagnosis of nonalcoholic fatty liver disease is practically assured. Only a liver biopsy, however, can confirm the diagnosis of Nonalcoholic fatty liver disease and Nonalcoholic steatohepatitis and determine the severity of the disease.
  • Whether or not it is vital to perform a liver biopsy in individuals with suspected nonalcoholic fatty liver disease or nonalcoholic steatohepatitis is still debated among liver specialists since no well-proven treatments are available. A liver biopsy can exclude other liver diseases as the cause of the abnormal tests or fat and provide information about the stage (and therefore the expected outcome) of Nonalcoholic fatty liver disease. It also may provide an incentive for an individual to adopt a healthy lifestyle (diet and exercise) with the aim of losing weight.
  • Weight loss, if overweight, and correcting elevated cholesterol, triglycerides, and blood sugar should be beneficial in Nonalcoholic fatty liver disease.

Treating Nonalcoholic Fatty Liver and Steatohepatitis Diseases: Real lasting Solutions with the Experts

 

Facebooktwitterpinterestlinkedin